drugset / Trial / NCT02872857
Subarachnoid Hemorrhage Recovery And Galantamine
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to examine the effects of the study drug--Galantamine-on patients with subarachnoid hemorrhage (SAH). The study will examine how patients with SAH will tolerate the study drug and how it may improve brain functioning in patients after SAH.
Timeline
- Start
- 2016-09
- Primary completion
- 2019-07-20
- Completion
- 2019-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Galantamine | Small molecule | 8 mg | — |
| Subject | Galantamine | Small molecule | 12 mg | — |
| Subject | Galantamine | Small molecule | — | — |